secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHAMPIONS ONCOLOGY, INC. (CSBR)
CIK:        0000771856
Form:       8-K
Filed at:   2026-03-30T23:59:59+00:00
Accession:  0001628280-26-021941
Event type: leadership
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Champions Oncology appoints Dr. Brian Alexander to board, replacing Dr. Philip Breitfeld
--------------------------------------------------------------------------------

- Board accepted resignation of Dr. Philip Breitfeld and appointed Dr. Brian Alexander effective March 24, 2026.
- Dr. Alexander is CEO of Valo Health and CEO-Partner at Flagship Pioneering; formerly CEO of Foundation Medicine.
- Appointment supports Champions' strategy to integrate patient-derived tumor models with molecular data for AI-driven R&D.
- Dr. Breitfeld's resignation was not due to any disagreement with the company's operations or policies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/771856/000162828026021941/0001628280-26-021941-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/771856/000162828026021941/csbr-20260324.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-021941

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer